Krishan Kumar
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
68
Citations
1,738
Est. group size
—
Recurring co-author estimate
Active years
44
Publishing since 1982
Krishan Kumar works on designing nanoparticle-based drug delivery systems, especially for treating cancers such as lung and breast cancer, as well as neurodegenerative conditions like Alzheimer's disease. His research combines materials science (e.g., lipid, polymer, and gold nanoparticles) with pharmacology to improve how drugs are targeted to specific organs or tumor sites while reducing side effects. He also studies plant-derived compounds and their potential to enhance chemotherapy outcomes.
Publication output has fluctuated over the last decade, peaking around 2021-2022 and showing a modest resurgence in 2025 after a dip in 2023-2024.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- CHD1 dysregulation in cancer: bridging chromatin instability, therapy resistance, and immune evasion
Molecular Biology Reports · 2025
- Organ-targeted drug delivery systems (OTDDS) of poly[( <i>N</i> -acryloylglycine)- <i>co</i> -( <i>N</i> -acryloyl- <scp>l</scp> -phenylalanine methyl ester)] copolymer library and effective treatment of triple-negative breast cancer
Journal of Materials Chemistry B · 2025
- Crafting a Molecular Trojan Horse: Sialic Acid-Modified PLGA Nanoparticles for Targeted Lung Cancer Therapy
Molecular Pharmaceutics · 2025
- Materials and Methods for Preparation of Pharmaceutical and Food Industry—Grade Lipid-Based Nanoparticles
2025
- Cationic Polyelectrolyte‐Polyphenol Complex Derived Gold Nanoparticles for Efficacious Anticancer Drug Delivery
Chemistry - An Asian Journal · 2025
- Epigallocatechin-3-gallate Synergistically Inhibits the Proliferation of Lung Cancer Cells with Gemcitabine by Induction of Apoptosis Mediated by ROS Generation
ACS Applied Bio Materials · 2024
- Evaluation of Gemcitabine and Epigallocatechin-3-Gallate Loaded Solid Lipid Nanoparticles on Benzopyrene Induced Lung Cancer Model Via Intranasal Route: Improved Pharmacokinetics and Safety Profile
AAPS PharmSciTech · 2024
- Potential significance of nanobiotechnology in food packaging
Elsevier eBooks · 2024
- Plant-mediated synthesis of nanoparticles and their applications: A review
Materials Research Bulletin · 2023
- Dual targeting pH responsive chitosan nanoparticles for enhanced active cellular internalization of gemcitabine in non-small cell lung cancer
International Journal of Biological Macromolecules · 2023
- In Vivo Cancer Microenvironment Responsive Glycan Receptor-Targeted Nanoparticles for Gemcitabine Delivery to Benzo[a]pyrene-Induced Lung Cancer Model
AAPS PharmSciTech · 2023
- pH-influenced self-assembled stealth nanoscaffolds encapsulating memantine for treatment of Alzheimer’s disease
Journal of Biosciences · 2023
- Recent development in the pharmaceutical industries
Elsevier eBooks · 2023
- Role of pro-inflammatory cytokines in Alzheimer's disease and neuroprotective effects of pegylated self-assembled nanoscaffolds
Current Research in Pharmacology and Drug Discovery · 2022
- New paradigm in combination therapy of siRNA with chemotherapeutic drugs for effective cancer therapy
Current Research in Pharmacology and Drug Discovery · 2022
- Current Research in Pharmacology and Drug Discovery×2
- ACS Applied Bio Materials×2
- ChemMedChem×2
- AAPS PharmSciTech×2
- Elsevier eBooks×2
- Robert J. Lee
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Sarah J. Shepherd
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Shi Du
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Congcong Xu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Dan Shu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile